A CRISPR/Cas12a-based digital microfluidic platform for parallel detection of foodborne pathogens
Analytica Chimica Acta · 2026-12 · 1426 · 346361
DOI: 10.1016/j.aca.2026.346361 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytica Chimica Acta, 2026-12. Verfasst von Yinglin Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: College of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai, 200093, PR China. Hauptthemen laut MEDLINE: Food Microbiology, CRISPR-Cas Systems, Microfluidic Analytical Techniques, Lab-On-A-Chip Devices. Die Arbeit nennt 43 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
BACKGROUND: Rapid and automated on-chip detection of multiple foodborne bacterial pathogens remains challenging because conventional molecular assays require multistep liquid handling and are difficult to integrate for parallel analysis. Here, we developed an EWOD-based DMF platform integrating RPA with CRISPR/Cas12a for parallel detection of S. aureus, E. coli O157:H7, L. monocytogenes, and C. sakazakii. The 16-site DMF chip was organized into four pathogen-specific detection modules, each containing a positive control, a negative control, and two replicate sample sites, enabling programmable droplet manipulation and sequential on-chip amplification and fluorescence detection without external pumps or complex valves. RESULTS: Assay conditions were systematically optimized for fluidic compatibility and CRISPR/Cas12a performance. Following off-chip sample preparation and genomic DNA extraction, the automated on-chip RPA amplification and CRISPR/Cas12a detection workflow was completed within approximately 50 min. Under these conditions, the platform achieved detection limits of 103, 102, 10, and 102 CFU/mL for S. aureus, E. coli O157:H7, L. monocytogenes, and C. sakazakii, respectively. No apparent cross-reactivity was observed among 35 food-associated bacterial strains. In artificially contaminated milk, milk powder, and chicken samples, comparable detection limits were obtained after off-chip sample processing, despite matrix-dependent variations in fluorescence intensity. SIGNIFICANCE: These results demonstrate that integrating EWOD-based digital microfluidics with RPA and CRISPR/Cas12a enables rapid, parallelized, and programmable molecular detection of multiple foodborne bacterial pathogens on a compact platform. By integrating droplet manipulation, amplification, and fluorescence detection on-chip, the proposed system reduces reliance on external fluidic components and provides a promising basis for further development toward automated and integrated food-safety testing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai, 200093, PR China.
- Institute of Agricultural Product Quality Safety and Nutrition, Zhejiang Academy of Agricultural Sciences, Hangzhou, 310021, PR China.
- China National Research Center for Food Safety Inspection and Testing, Beijing, 100000, PR China.
- Linyi University, Linyi, 276000, PR China. Electronic address: tianyachen@lyu.edu.cn.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Wang, Y., Wu, Y., Huang, X., Tian, Y., & Liu, Q. (2026). A CRISPR/Cas12a-based digital microfluidic platform for parallel detection of foodborne pathogens. Analytica Chimica Acta, 1426, 346361. https://doi.org/10.1016/j.aca.2026.346361
Vancouver
Wang Y, Wu Y, Huang X, Tian Y, Liu Q. A CRISPR/Cas12a-based digital microfluidic platform for parallel detection of foodborne pathogens. Analytica Chimica Acta. 2026;1426:346361. doi:10.1016/j.aca.2026.346361
BibTeX
@article{Wang2026,
author = {Wang, Yinglin and Wu, Yafang and Huang, Xiaotian and Tian, Yachen and Liu, Qing},
title = {A CRISPR/Cas12a-based digital microfluidic platform for parallel detection of foodborne pathogens},
journal = {Analytica Chimica Acta},
year = {2026},
volume = {1426},
pages = {346361},
doi = {10.1016/j.aca.2026.346361}
}
EUVIMED